Century Therapeutics
IPSC • NASDAQ
Century Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brent Pfeiffenberger, with a market cap of $406.2M.
Market Cap$406.2M
Employees165.0
CEOBrent Pfeiffenberger
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · in a monthQ1 2026
Financials
Century Therapeutics FAQ
Common questions about Century Therapeutics
Century Therapeutics is scheduled to report earnings for Q1 2026 on May 14, 2026.
Century Therapeutics has approximately 165 employees.